{"nct_id":"NCT06997588","title":"EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)","status":"NOT_YET_RECRUITING","status_verified_date":"2025-05","start_date":"2025-10-21","start_date_type":"ESTIMATED","primary_completion_date":"2028-08-02","primary_completion_date_type":"ESTIMATED","completion_date":"2030-09-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVS"]}